Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025
Bristol Myers Squibb (NYSE: BMY) has announced it will release its fourth quarter 2024 financial results on Thursday, February 6, 2025. The company will host a conference call and live webcast at 8:00 a.m. ET on the same day, where executives will review financial results and address questions from investors and analysts.
Investors and the public can participate through a live webcast at investor.bms.com or by registering for the conference call. Those unable to register can dial 1-833-816-1116 (U.S. toll-free) or +1 412-317-0705 (international). A replay will be available until February 20, 2025.
Bristol Myers Squibb (NYSE: BMY) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre 2024 giovedì 6 febbraio 2025. L'azienda ospiterà una conference call e una diretta webcast alle 8:00 ora ET nello stesso giorno, durante la quale i dirigenti presenteranno i risultati finanziari e risponderanno alle domande di investitori e analisti.
Gli investitori e il pubblico possono partecipare tramite una diretta webcast su investor.bms.com o registrandosi per la conference call. Coloro che non riescono a registrarsi possono comporre il numero 1-833-816-1116 (gratis dagli USA) o +1 412-317-0705 (internazionale). Una registrazione sarà disponibile fino al 20 febbraio 2025.
Bristol Myers Squibb (NYSE: BMY) ha anunciado que publicará sus resultados financieros del cuarto trimestre de 2024 el jueves 6 de febrero de 2025. La empresa organizará una conferencia telefónica y una transmisión en vivo a las 8:00 a.m. ET en el mismo día, donde los ejecutivos revisarán los resultados financieros y responderán preguntas de inversores y analistas.
Los inversores y el público pueden participar a través de una transmisión en vivo en investor.bms.com o registrándose para la conferencia telefónica. Aquellos que no puedan registrarse pueden llamar al 1-833-816-1116 (número gratuito en EE. UU.) o al +1 412-317-0705 (internacional). Se dispondrá de una grabación hasta el 20 de febrero de 2025.
Bristol Myers Squibb (NYSE: BMY)는 2024년 4분기 재무 결과를 2025년 2월 6일 목요일에 발표한다고 발표했습니다. 회사는 그날 오전 8시 ET에 컨퍼런스 콜과 생중계 웹캐스트를 개최하며, 경영진이 재무 결과를 검토하고 투자자 및 분석가의 질문에 답변할 것입니다.
투자자와 대중은 investor.bms.com의 생중계를 통해 참여하거나 컨퍼런스 콜을 등록하여 참여할 수 있습니다. 등록할 수 없는 경우 1-833-816-1116(미국 무료) 또는 +1 412-317-0705(국제)로 전화할 수 있습니다. 녹화는 2025년 2월 20일까지 제공될 것입니다.
Bristol Myers Squibb (NYSE: BMY) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre 2024 le jeudi 6 février 2025. La société organisera une conférence téléphonique et une diffusion en direct à 8h00 ET le même jour, au cours de laquelle les dirigeants passeront en revue les résultats financiers et répondront aux questions des investisseurs et des analystes.
Les investisseurs et le grand public peuvent participer via un webinaire en direct sur investor.bms.com ou en s'inscrivant à la conférence téléphonique. Ceux qui ne peuvent pas s'inscrire peuvent composer le 1-833-816-1116 (numéro gratuit aux États-Unis) ou le +1 412-317-0705 (international). Un enregistrement sera disponible jusqu'au 20 février 2025.
Bristol Myers Squibb (NYSE: BMY) hat bekannt gegeben, dass es seine Finanzergebnisse für das vierte Quartal 2024 am Donnerstag, den 6. Februar 2025, veröffentlichen wird. Das Unternehmen wird an diesem Tag um 8:00 Uhr ET eine Telefonkonferenz und einen Live-Stream abhalten, in der die Führungskräfte die Finanzergebnisse besprechen und Fragen von Investoren und Analysten beantworten werden.
Investoren und die Öffentlichkeit können über einen Live-Stream auf investor.bms.com teilnehmen oder sich für die Telefonkonferenz registrieren. Wer sich nicht registrieren kann, kann die Nummer 1-833-816-1116 (kostenlos in den USA) oder +1 412-317-0705 (international) anrufen. Eine Wiederholung ist bis zum 20. Februar 2025 verfügbar.
- None.
- None.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Investors and the public can register for the live conference call here. Those unable to register can access the live conference call by dialing in the
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on February 6, 2025, through 11:30 a.m. ET on February 20, 2025, by dialing in the
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20241219830221/en/
Media:
media@bms.com
Investors:
investor.relations@bms.com
Source: Bristol Myers Squibb
FAQ
When will Bristol Myers Squibb (BMY) release Q4 2024 earnings?
What time is BMY's Q4 2024 earnings call?
How can investors access BMY's Q4 2024 earnings call?
How long will BMY's Q4 2024 earnings call replay be available?
